• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭中恶病质的机制。

Mechanisms for cachexia in heart failure.

作者信息

Pureza Vincent, Florea Viorel G

机构信息

Department of Internal Medicine, University of Minnesota Medical School, 420 Delaware Street SE, Minneapolis, MN, 55455, USA,

出版信息

Curr Heart Fail Rep. 2013 Dec;10(4):307-14. doi: 10.1007/s11897-013-0153-9.

DOI:10.1007/s11897-013-0153-9
PMID:23925442
Abstract

The combination of profound muscle wasting and severe weight loss that occurs in heart failure is a complex phenomenon that involves the interplay of numerous factors. In this article, we describe processes that contribute to cachexia, as part of the clinical sequelae of heart failure, and their potential underlying mechanisms. While multiple mechanisms of cardiac cachexia have been described, we propose a multifactorial etiology for this condition that includes, but is not limited to, nutritional and gastrointestinal alterations, immunological and neurohormonal activation, and anabolic and catabolic imbalance.

摘要

心力衰竭时出现的严重肌肉萎缩和体重严重减轻相结合是一种复杂的现象,涉及众多因素的相互作用。在本文中,我们描述了作为心力衰竭临床后遗症一部分的恶病质促成过程及其潜在的潜在机制。虽然已经描述了心脏恶病质的多种机制,但我们提出这种情况的多因素病因,包括但不限于营养和胃肠道改变、免疫和神经激素激活以及合成代谢和分解代谢失衡。

相似文献

1
Mechanisms for cachexia in heart failure.心力衰竭中恶病质的机制。
Curr Heart Fail Rep. 2013 Dec;10(4):307-14. doi: 10.1007/s11897-013-0153-9.
2
Heart failure-induced cachexia.心力衰竭相关性恶病质。
Arq Bras Cardiol. 2013 May;100(5):476-82. doi: 10.5935/abc.20130060. Epub 2013 Apr 9.
3
Neurohormonal factors in the development of catabolic/anabolic imbalance and cachexia.分解代谢/合成代谢失衡及恶病质发展过程中的神经激素因素
Int J Cardiol. 2002 Sep;85(1):111-21, discussion 121-4. doi: 10.1016/s0167-5273(02)00239-5.
4
Pathophysiology of peripheral muscle wasting in cardiac cachexia.心脏恶病质中周围肌肉萎缩的病理生理学
Curr Opin Clin Nutr Metab Care. 2005 May;8(3):249-54. doi: 10.1097/01.mco.0000165002.08955.5b.
5
Cardiac Cachexia: Perspectives for Prevention and Treatment.心脏恶病质:预防与治疗的前景
Arq Bras Cardiol. 2017 Jan;108(1):74-80. doi: 10.5935/abc.20160142. Epub 2016 Oct 27.
6
The syndrome of cardiac cachexia.心脏恶病质综合征
Int J Cardiol. 2002 Sep;85(1):51-66. doi: 10.1016/s0167-5273(02)00233-4.
7
Myostatin: Regulator of muscle wasting in heart failure and treatment target for cardiac cachexia.肌生成抑制素:心力衰竭中肌肉萎缩的调节因子及心脏恶病质的治疗靶点。
Circulation. 2010 Jan 26;121(3):354-6. doi: 10.1161/CIR.0b013e3181d0ba8b. Epub 2010 Jan 11.
8
Biomarkers for cardiac cachexia: reality or utopia.心脏恶病质的生物标志物:现实还是乌托邦。
Clin Chim Acta. 2014 Sep 25;436:323-8. doi: 10.1016/j.cca.2014.06.022. Epub 2014 Jun 28.
9
The impact of cachexia on cardiorespiratory reflex control in chronic heart failure.恶病质对慢性心力衰竭患者心肺反射控制的影响。
Eur Heart J. 1999 Nov;20(22):1667-75. doi: 10.1053/euhj.1999.1525.
10
Prognosis and therapy approaches of cardiac cachexia.心脏恶病质的预后与治疗方法
Curr Opin Cardiol. 2006 May;21(3):229-33. doi: 10.1097/01.hco.0000221585.94490.09.

引用本文的文献

1
Weight loss during follow-up in patients with acute heart failure: From the KCHF registry.随访期间急性心力衰竭患者的体重减轻:来自 KCHF 登记研究。
PLoS One. 2023 Jun 23;18(6):e0287637. doi: 10.1371/journal.pone.0287637. eCollection 2023.
2
Association of an Increased Abnormal Mitochondria Ratio in Cardiomyocytes with a Prolonged Oxygen Uptake Time Constant during Cardiopulmonary Exercise Testing of Patients with Non-ischemic Cardiomyopathy.在非缺血性心肌病患者心肺运动试验中,心肌细胞中线粒体比例增加与氧摄取时间常数延长相关。
Intern Med. 2023 Aug 1;62(15):2163-2170. doi: 10.2169/internalmedicine.0697-22. Epub 2022 Nov 30.
3

本文引用的文献

1
Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure.肥胖和肥胖悖论对心力衰竭患病率和预后的影响。
JACC Heart Fail. 2013 Apr;1(2):93-102. doi: 10.1016/j.jchf.2013.01.006. Epub 2013 Apr 1.
2
Heart failure-induced cachexia.心力衰竭相关性恶病质。
Arq Bras Cardiol. 2013 May;100(5):476-82. doi: 10.5935/abc.20130060. Epub 2013 Apr 9.
3
Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure.心肺适能对心力衰竭患者肥胖悖论的影响。
The impact of pre-transplant weight loss on survival following cardiac transplantation.
移植前体重减轻对心脏移植后生存的影响。
Clin Transplant. 2022 Dec;36(12):e14831. doi: 10.1111/ctr.14831. Epub 2022 Nov 9.
4
The RAF Kinase Inhibitor Protein (RKIP): Good as Tumour Suppressor, Bad for the Heart.RAF 激酶抑制剂蛋白(RKIP):既是肿瘤抑制因子,也是心脏杀手。
Cells. 2022 Feb 14;11(4):654. doi: 10.3390/cells11040654.
5
Combining Prognostic Nutritional Index and Brain Natriuretic Peptide as a Predicting Tool for Heart Transplantation.联合预后营养指数和脑钠肽作为心脏移植的预测工具
J Cardiovasc Dev Dis. 2022 Jan 24;9(2):40. doi: 10.3390/jcdd9020040.
6
Impact of Melatonin and Branched-Chain Amino Acids Cosupplementation on Quality of Life, Fatigue, and Nutritional Status in Cachectic Heart Failure Patients: A Randomized Controlled Trial.褪黑素与支链氨基酸联合补充对恶病质心力衰竭患者生活质量、疲劳及营养状况的影响:一项随机对照试验
Am J Lifestyle Med. 2019 Sep 14;16(1):130-140. doi: 10.1177/1559827619874044. eCollection 2022 Jan-Feb.
7
Cardiac Cachexia Associated With Valvular Heart Failure.与瓣膜性心力衰竭相关的心脏恶病质
Cureus. 2021 Dec 2;13(12):e20109. doi: 10.7759/cureus.20109. eCollection 2021 Dec.
8
Factors associated with unintentional weight loss among older adults in a geriatric outpatient clinic of university hospital.老年大学医院老年门诊患者非故意体重减轻的相关因素。
PLoS One. 2021 Nov 18;16(11):e0260233. doi: 10.1371/journal.pone.0260233. eCollection 2021.
9
Cardiac Obesity and Cardiac Cachexia: Is There a Pathophysiological Link?心脏性肥胖与心脏恶病质:是否存在病理生理联系?
J Obes. 2019 Sep 2;2019:9854085. doi: 10.1155/2019/9854085. eCollection 2019.
10
Pharmacological management of cardiac cachexia: a review of potential therapy options.心脏恶病质的药物治疗管理:潜在治疗选择的综述。
Heart Fail Rev. 2019 Sep;24(5):617-623. doi: 10.1007/s10741-019-09784-3.
Mayo Clin Proc. 2013 Mar;88(3):251-8. doi: 10.1016/j.mayocp.2012.11.020. Epub 2013 Feb 27.
4
Effects of fish oil supplementation on inflammatory markers in chronic heart failure: a meta-analysis of randomized controlled trials.鱼油补充剂对慢性心力衰竭炎症标志物的影响:一项随机对照试验的荟萃分析。
BMC Cardiovasc Disord. 2012 Sep 20;12:77. doi: 10.1186/1471-2261-12-77.
5
The obesity paradox, cardiorespiratory fitness, and coronary heart disease.肥胖悖论、心肺适能与冠心病。
Mayo Clin Proc. 2012 May;87(5):443-51. doi: 10.1016/j.mayocp.2012.01.013. Epub 2012 Apr 12.
6
Beta-blockers and weight change in patients with chronic heart failure.β受体阻滞剂与慢性心力衰竭患者体重变化。
J Card Fail. 2012 Mar;18(3):233-7. doi: 10.1016/j.cardfail.2011.10.016. Epub 2011 Dec 3.
7
The role of exercise training in heart failure.运动训练在心力衰竭中的作用。
J Am Coll Cardiol. 2011 Aug 2;58(6):561-9. doi: 10.1016/j.jacc.2011.04.020.
8
Impaired muscle protein anabolic response to insulin and amino acids in heart failure patients: relationship with markers of immune activation.心力衰竭患者的肌肉蛋白对胰岛素和氨基酸的合成代谢反应受损:与免疫激活标志物的关系。
Clin Sci (Lond). 2010 Aug 17;119(11):467-76. doi: 10.1042/CS20100110.
9
Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study.长效睾酮治疗对老年慢性心力衰竭患者功能运动能力、骨骼肌性能、胰岛素抵抗和压力反射敏感性的影响:一项双盲、安慰剂对照、随机研究
J Am Coll Cardiol. 2009 Sep 1;54(10):919-27. doi: 10.1016/j.jacc.2009.04.078.
10
ESPEN Guidelines on Parenteral Nutrition: on cardiology and pneumology.欧洲临床营养与代谢学会(ESPEN)胃肠外营养指南:心脏病学与肺病学领域
Clin Nutr. 2009 Aug;28(4):455-60. doi: 10.1016/j.clnu.2009.04.023. Epub 2009 Jun 9.